This study provides comprehensive insights into the biochemical, histopathological, immunohistochemical, and molecular characteristics of familial breast cancer among Egyptian women, highlighting the pivotal role of ERBB2 (HER2/neu) overexpression in disease pathogenesis and its potential as a diagnostic and prognostic biomarker. This evidence concerns the gene ERBB2 and breast carcinoma.